SEI Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

SEI Investments’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,690	Closed	-$650K	–	2692
2021 Q3	$650K	Sell	25,690 -13,845	-35%	-$407K	﹤0.01%	1950
2021 Q2	$1.38M	Buy	39,535 +11,129	+39%	+$435K	﹤0.01%	1668
2021 Q1	$1.16M	Buy	28,406 +367	+1%	+$16.9K	﹤0.01%	1696
2020 Q4	$1.22M	Sell	28,039 -24,689	-47%	-$1.22M	﹤0.01%	1617
2020 Q3	$2.91M	Sell	52,728 -19,751	-27%	-$1.26M	0.01%	1121
2020 Q2	$4.58M	Buy	72,479 +14,874	+26%	+$1.02M	0.01%	904
2020 Q1	$2.94M	Buy	57,605 +27,778	+93%	+$1.86M	0.01%	983
2019 Q4	$2.37M	Buy	+29,827	New	+$1.77M	0.01%	1252
2019 Q3	–	Sell	-23,751	Closed	-$1.28M	–	2445
2019 Q2	$1.28M	Buy	23,751 +20,291	+586%	+$1.17M	﹤0.01%	1513
2019 Q1	$183K	Sell	3,460 -3,970	-53%	-$195K	﹤0.01%	2314
2018 Q4	$282K	Hold	7,430	–	–	﹤0.01%	1919
2018 Q3	$282K	Sell	7,430 -6,420	-46%	-$284K	﹤0.01%	1826
2018 Q2	$626K	Buy	13,850 +1,499	+12%	+$68.3K	﹤0.01%	1745
2018 Q1	$597K	Buy	+12,351	New	+$689K	﹤0.01%	1576

Other funds holding GBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SEI Investments's GBT Position: Q4 2021 in Review

SEI Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2021, closing a stake of 25,690 shares — an estimated $650K sold.

SEI Investments first reported a position in GBT in Q1 2018 and held it in 14 quarters. The position peaked at $4.58M in Q2 2020. 206 funds tracked by Wall St. Rank hold GBT as of Q4 2021.

SEI Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
SEI Investments sold 25,690 Global Blood Therapeutics, Inc. shares in Q4 2021, an estimated $650K.
SEI Investments first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 14 quarters.
SEI Investments's Global Blood Therapeutics, Inc. position peaked at $4.58M in Q2 2020.
206 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2021.

Based on SEI Investments's 13F filing for Q4 2021, filed 14 Feb 2022.